New JAMA Study Led by Dr. Roberto Caricchio

Media outlets, including Healio Rheumatology, HCPLive and Daily Mail, highlighted a new study published in JAMA authored by Roberto Caricchio, MD, FACR examining the effect of the IL-1 inhibitor canakinumab (Ilaris) vs. placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19.